Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Health Canada recalls over-dosage ophthalmic solution

This article was originally published in Scrip

Executive Summary

Health Canada and Sandoz Canada has issued a recall of Sandoz Timolol Ophthalmic Solution 0.25% and 0.5% eye drops, as some bottles may contain more of the active ingredient timolol maleate than indicated. The products are used to treat intraocular pressure and glaucoma. The formulations may cause potential adverse events including eye irritation, dizziness, headache, low blood pressure, difficulty breathing and cardiac failure, and patients currently using the solution are advised to discontinue use, consult their physician and return products to a pharmacist for safe disposal. As of July 21st, no adverse events had been reported in Canada.





Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts